Description

NovoFine Autocover is an innovative safety pen needle designed by Novo Nordisk to enhance the safety and comfort of subcutaneous injections, such as those required for insulin administration. This single-use, disposable needle is engineered with a range of features to address common concerns associated with injection devices.

Key Features

• Automatic Safety Lock: One of the standout features of NovoFine Autocover is its automatic safety lock mechanism. This activates immediately after injection, significantly reducing the risk of needle stick injuries and preventing reuse.

• Concealed Needle Design: The needle is concealed by a plastic shield before, during, and after use. This design not only helps in reducing needle anxiety but also ensures safer handling.

• Red Safety Indicator: A red indicator provides a clear visual confirmation when the safety lock is engaged, offering additional peace of mind.

Specifications

• Needle Size: 30 gauge (0.3 mm diameter) x 8 mm length (1/3 inch)
• Material: Made from stainless steel with a plastic hub and shield
• Design: Ultra-thin wall for more comfortable injections

Compatibility

NovoFine Autocover is compatible with a wide range of insulin injection devices, including:

• FlexPen®
• FlexTouch®
• InnoLet®
• Victoza®
• NovoPen® (3, 4, 5)
• NovoPen Echo®
• Omnipod®
• Sensa®

Instructions for Use

To use, simply remove the paper tab and screw the needle onto the pen device. After the injection, the safety lock engages automatically. Users are advised to dispose of the needle in a puncture-resistant container following local regulations and healthcare professional guidance.

Precautions

• Not recommended for use by individuals who are blind or visually impaired without assistance.
• Proper training is advised before use.
• Do not attempt to reuse or recap the needle.

NovoFine Autocover is a sterile, non-toxic, and non-pyrogenic device, maintaining its sterility as long as the paper tab and needle cap remain unbroken. This product is designed to provide a safer, more comfortable injection experience, aligning with Novo Nordisk's commitment to quality and innovation in healthcare solutions.